bluuebunny/crossref_metadata_2025_split huggingface dataset:
Crystal structure of the antibiotic SY-1 (20-deoxy-salinomycin): sodium 2-(6-[2- (5-ethyl-5-hydroxy-6-methyl-tetrahydro-pyran-2-yl)-2,10,12-trimethyl- 1,6,8-trioxa-dispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxo-heptyl-5-methyl-tetrahydro-pyran-2-yl)-butyrate—methanol solvate (1:0.69), C42H69NaO10 · 0.69CH3OH
Authors: Paulus E. F. , Vértesy L. 
Published: September 2014

Abstract C42.693H71.772NaO10.693, orthorhombic, P212121 (No. 19), a = 11.295(1) Å, b = 18.628(1) Å, c = 21.823(1) Å, V = 4591.6 Å3, Z = 4, Rgt(F) = 0.037, wRref(F2) = 0.099, T = 293 K.
Crystal structure of di(1,10-phenanthroline-N,N′)di[μ-(2-furancarboxylato- O,O′)-μ-(2-furancarboxylato-O,O′:O′)]di(nitrato)disamarium(III), Sm2(NO)2(C5H3O3)4(C12H8N2)2
Authors: Li X. , Zou Y.-Q. , Song H.-B. 
Published: September 2014

AbstractC22H14N3O9Sm, triclinic, P1̅ (no. 2), a = 10.400(4) Å, b = 10.584(4) Å, c = 11.093(4) Å, α = 81.437(6)°, β = 88.599(6)°, γ = 67.888(5)°, V = 1118.0 Å3, Z = 2, Rgt(F) = 0.036, wRref(F2) = 0.069, T = 293 K.
Refinement of the crystal structure of zirconium monobismuthide, ZrBi
Authors: Boström M. , Prots Yu. , Grin Yu. 
Published: September 2014

Abstract BiZr, orthorhombic, Cmcm (no. 63), a = 3.858(2) Å, b = 10.770(2) Å, c = 14.325(3) Å, V = 595.2 Å3, Z = 12, Rgt(F) = 0.026, wRref(F) = 0.044, T = 293 K.
Crystal structure of diaqua-bis(pyridine)-μ2-squarato(1,3)-zinc(II), Zn(C4O4)(C5H5N)2(H2O)2
Authors: Kirchmaier R. , Altin E. , Lentz A. 
Published: September 2014

Abstract C14H14N2O6Zn, orthorhombic, Pbca (no. 61), a = 7.982(1) Å, b = 12.028(2) Å, c = 15.721(2) Å, V = 1509.4 Å3, Z = 4, Rgt(F) = 0.030, wRref(F2) = 0.078, T = 293 K.
Crystal structure of sodium 4-azidobenzenesulfonate, Na[N3C6H4SO3]
Authors: Biesemeier Frank , Harms Klaus , Müller Ulrich 
Published: September 2014

AbstractC6H4N3NaO3S, monoclinic, P121/c1 (no. 14), a = 17.816(1) Å, b = 8.3131(7) Å, c = 5.9366(5) Å, β = 93.061(6)°, V = 878.0 Å3, Z = 4, Rgt(F) = 0.026, wRref(F2) = 0.073, T = 193 K.
Crystal structure of bis(μ2-aqua)diaquasodium 4-azidobenzenesulfonate monohydrate, Na(H2O)4[N3C6H4SO3] · H2O
Authors: Biesemeier Frank , Harms Klaus , Müller Ulrich 
Published: September 2014

Abstract C6H14N3NaO8S, monoclinic, P121/c1 (no. 14), a = 7.018(1) Å, b = 27.193(5) Å, c = 7.089(1) Å, β = 92.01(2)°, V = 1352.0 Å3, Z = 4, Rgt(F) = 0.071, wRref(F2) = 0.160, T = 193 K.
Crystal structure of N,N,N′,N′-tetra-m-tolyl-anthracene-9,10-diamine, C42H36N2
Authors: Yu M.-X. 
Published: September 2014

Abstract C42H36N2, monoclinic, P121/c1 (no. 14), a = 8.279(3) Å, b = 16.998(6) Å, c = 11.812(4) Å, β = 93.599(7)°, V = 1659.0 Å3, Z = 2, Rgt(F) = 0.068, wRref(F2) = 0.161, T = 295 K.
Crystal structure of tetraaqua(4,4′-bipyridine-N,N′)copper(II) fumarate tetrahydrate, Cu(H2O)4(C10H8N2)(C4H2O4) · 4H2O
Authors: Ying E.-B. , Zheng Y.-Q. , Zhou Q.-Q. 
Published: September 2014

Abstract C14H26CuN2O12, monoclinic, C12/c1 (no. 15), a = 16.631(3) Å, b = 11.155(2) Å, c = 13.096(3) Å, β = 125.08(3)°, V = 1988.3 Å3, Z = 4, Rgt(F) = 0.038, wRref(F2) = 0.094, T = 293 K.
Crystal structure of 5,10,15,20-tetrakis(5′-methylthien-2′-yl)porphyrin, C40H30N4S4
Authors: Bellizzi M. , Foss P. C. D. , Pelto R. , Crundwell G. , Brückner C. , Updegraff J. B. , Zeller M. , Hunter A. D. 
Published: September 2014

Abstract C40H30N4S4, triclinic, P1̅ (no. 2), a = 6.5126(7) Å, b = 10.499(1) Å, c = 12.635(1) Å, α = 87.818(2)°, β = 79.141(2)°, γ = 86.737(2)°, V = 846.7 Å3, Z = 1, Rgt(F) = 0.057, wRref(F2) = 0.150, T = 100 K.
Crystal structure of aqua[1,3-bis(2-pyridylimino)isoindolinato](salicylato)- copper(II), Cu(C7O3H4)(C18H12N5)(H2O)
Authors: Kaizer J. , Pap J. , Speier G. , Párkányi L. 
Published: September 2014

Abstract C25H18CuN5O4, triclinic, P1̅ (no. 2), a = 7.300(1) Å, b = 11.985(1) Å, c = 13.190(1) Å, α = 88.15(1)°, β = 78.68(1)°, γ = 78.62(1)°, V = 1109.3 Å3, Z = 2, Rgt(F) = 0.048, wRref(F2) = 0.134, T = 293 K.
Crystal structure of 2-hydroxyimino-3-oxo-3-phenyl-propionic acid ethyl ester, C11H11NO4
Authors: Ramos Silva M. , Matos Beja A. , Paixão J. A. , Lopes S. H. , Cabral Ana M. T. D. P. V. , Rocha Gonsalves A. M. d′A. , Sobral A. J. F. N. 
Published: September 2014

Abstract C11H11NO4, orthorhombic, Pna21 (no. 33), a = 18.370(4) Å, b = 4.870(1) Å, c = 24.616(2) Å, V = 2202.4 Å3, Z = 8, Rgt(F) = 0.082, wRref(F2) = 0.203, T = 293 K.
Crystal structure of bis(8-chloro-5-(4-methylpiperazinium-1-yl)pyrido- [2,3-b][1,5]benzoxazepine) fumarate – fumaric acid solvate (1:1), (C17H18ClN4O)2(C4H2O4) · C4H4O4
Authors: Dupont L. , Liégeois J.-F. 
Published: September 2014

Abstract C42H42Cl2N8O10, triclinic, P1̅ (no. 2), a = 9.625(1) Å, b = 9.929(3) Å, c = 11.860(2) Å, α = 108.12(2)°, β = 73.24(1)°, γ = 87.38(1)°, V = 1019.9 Å3, Z = 1, Rgt(F) = 0.043, wRref(F2) = 0.131, T = 293 K.
Crystal structure of diaquatetra(3,5-dinitrobenzoato)tetrasilver(I), Ag4(C7H3N2O6)4(H2O)2
Authors: Xia J. , Wang Z.-G. , Yang L. , Tang L.-L. , Zhu H.-L. 
Published: September 2014

Abstract C28H16Ag4N8O26, monoclinic, P121/c1 (no. 14), a = 5.667(1) Å, b = 16.915(3) Å, c = 19.694(4) Å, β = 90.38(3)°, V = 1887.8 Å3, Z = 2, Rgt(F) = 0.065, wRref(F2) = 0.177, T = 293 K.
Crystal structure of catena-bis-μ-terephthalato[2,2′-bipyridinecobalt(II)] [aqua-2,2′-bipyridinecobalt(II)], Co2(C8H4O4)2(C10H8N2)2(H2O)
Authors: Chen F. , Hu M.-L. , Ye M.-D. , Xiao H.-P. 
Published: September 2014

Abstract C36H26Co2N4O9, monoclinic, P121/c1 (no. 14), a = 13.8648(7) Å, b = 17.1789(9) Å, c = 14.1938(7) Å, β = 104.525(1)°, V = 3272.7 Å3, Z = 4, Rgt(F) = 0.076, wRref(F2) = 0.151, T = 298 K.
Crystal structure of 2-(3-methoxyphenylethynyl)-6-methylpyridine, C15H13NO, M-MPEP – a mGluR5 antagonist
Authors: Alagille D. , Baldwin R. M. , Incarvito C. D. , Tamagnan G. 
Published: September 2014

Abstract C15H13NO, monoclinic, P121/c1 (no. 14), a = 15.986(3) Å, b = 6.760(1) Å, c = 11.415(2) Å, β = 104.63(3)°, V = 1193.5 Å3, Z = 4, Rgt(F) = 0.055, wRref(F2) = 0.139, T = 183 K.
Crystal structure of 4-methylanilinium dihydrogenphosphate, ( p-CH3C6H4NH3)(H2PO4)
Authors: Smirani W. , Ben Slimane A. , Rzaigui M. 
Published: September 2014

Abstract C7H12NO4P, orthorhombic, Pbca (no. 61), a = 7.790(3) Å, b = 24.645(4) Å, c = 9.867(2) Å, V = 1894.3 Å3, Z = 8, Rgt(F) = 0.048, wRref(F) = 0.053, T = 296 K.
Crystal structure of (3S,4S)-4,5-O-cyclohexylidene-4,5-dihydroxy-3- methylamino-pentanoic acid hydrochloride, (C12H22NO4)Cl
Authors: Frey W. , Henneböhle M. , Jäger V. 
Published: September 2014

Abstract C12H22ClNO4, monoclinic, P1211 (no. 4), a = 6.2327(3) Å, b = 7.9360(3) Å, c = 14.1536(5) Å, β = 99.709(4)°, V = 690.1 Å3, Z = 2, Rgt(F) = 0.042, wRref(F2) = 0.115, T = 293 K.
Crystal structure of samarium nickel aluminide, Sm4Ni6Al23
Authors: Fornasini M. L. , Raggio R. , Borzone G. 
Published: September 2014

Abstract Al23Ni6Sm4, monoclinic, C12/m1 (no. 12), a = 15.939(3) Å, b = 4.0967(6) Å, c = 18.320(3) Å, β = 113.09(2)°, V = 1100.4 Å3, Z = 2, Rgt(F) = 0.017, wRobs(F2) = 0.040, T = 293 K.
Crystal structure of dieuropium and distrontium di(lithium, magnesium) trigermanide, M2LixMg2–xGe3 (M= Eu, x = 1.16;M= Sr, x = 0.94)
Authors: Xie Q.-X. , Nesper R. 
Published: September 2014

Abstract Eu2Ge3Li1.16Mg0.84, orthorhombic, Cmcm (no. 63), a = 4.577(1) Å, b = 19.534(4) Å, c = 7.223(2) Å, V = 645.7 Å3, Z = 4, Rgt(F) = 0.030, wRref(F2) = 0.072, T = 293 K.Ge3Li0.94Mg1.06Sr2, orthorhombic, Cmcm (no. 63), a = 4.6357(3) Å, b = 19.703(1) Å, c = 7.3239(5) Å, V = 669.0 Å3, Z = 4, Rgt(F) = 0.023, wRref(F2) = 0.047, T = 293 K.
Crystal structure of dithallium(I) octa-μ3-bromohexabromo-octahedrohexamolybdate, Tl2[(Mo6Br8)Br6]
Authors: Xu W. , Zheng Y.-Q. , Wang P. 
Published: September 2014

Abstract Br14Mo6Tl2, cubic, Pn3̅ (no. 201), a = 13.813(1) Å, V = 2635.4 Å3, Z = 4, Rgt(F) = 0.080, wRref(F2) = 0.147, T = 295 K.
Crystal structure of cobalt aluminum silicide, Co10+xAl23Si9–2x (x = 0.14), the φ phase in the Co-Al-Si system
Authors: Richter K. W. , Prots Yu. 
Published: September 2014

Abstract Al23Co10.14Si8.72, orthorhombic, Pnma (no. 62), a = 13.852(3) Å, b = 23.055(5) Å, c = 7.340(2) Å, V = 2344.1 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.081, T = 293 K.
Crystal structure of 4-ethyl-5-{[(4-methyl-4H-1,2,4-triazol-3-yl)- sulfanyl]methyl}-4H-1,2,4-triazole-3(2H)-thione, C8H12N6S2, the orthorhombic modification
Authors: Mazur L. , Koziol A. E. , Maliszewska-Guz A. , Wujec M. , Pitucha M. , Dobosz M. 
Published: September 2014

Abstract C8H12N6S2, orthorhombic, Iba2 (no. 45), a = 21.802(4) Å, b = 8.821(2) Å, c = 12.676(4) Å, V = 2437.8 Å3, Z = 8, Rgt(F) = 0.039, wRref(F2) = 0.104, T = 293 K.
Crystal structure of N-methoxy-N-methyl-2-[(4'-nitrophenyl)sulfinyl]- propanamide, C11H14N2O5S
Authors: Zukerman-Schpector J. , Domingues N. L. C. , Mondino M. G. , Reis A. K. C. A. , Rittner R. , Lima F. S. 
Published: September 2014

AbstractC11H14N2O5S, monoclinic, P121/c1 (no. 14), a = 7.4329(9) Å, b = 23.631(3) Å, c = 7.900(1) Å, β = 110.723(8)°, V = 1297.9 Å3, Z = 4, Rgt(F) = 0.045, wRref(F2) = 0.114, T = 293 K.
Crystal structure of 1-[2,4,6-tris(benzoyloxy)phenyl]ethanone, C29H20O7
Authors: Shi J. , Zhang Z.-T. 
Published: September 2014

AbstractC29H20O7, monoclinic, P121/c1 (no. 14), a = 9.583(4) Å, b = 25.30(1) Å, c = 19.975(9) Å, β = 96.732(8)°, V = 4809.0 Å3, Z = 8, Rgt(F) = 0.071, wRref(F2) = 0.189,T = 298 K.
Crystal structure of dimethylammonium bis(salicylato)borate, [NH2(CH3)2][BO4(C7H4O)2]
Authors: Li P. , Liu Z.-H. 
Published: September 2014

Abstract C16H16BNO6, orthorhombic, Aba2 (no. 41), a = 8.544(7) Å, b = 19.68(2) Å, c = 9.117(7) Å, V = 1532.9 Å3, Z = 4, Rgt(F) = 0.052, wRref(F2) = 0.136, T = 298 K.
Crystal structure of dimethanol-bis(1,3-bis(3,5-dimethylpyrazol-1-yl)- propan-2-olato)dicopper(II) dibromide, [Cu2(C13H19N4O)2(CH3OH)2]Br2
Authors: Zhang G.-F. , Dou Y.-L. , She J.-B. , Yin M.-H. 
Published: September 2014

Abstract C28H46Br2Cu2N8O4, orthorhombic, Pbca (no. 61), a = 11.914(4) Å, b = 16.368(5) Å, c = 18.237(6) Å, V = 3556.4 Å3, Z = 4, Rgt(F) = 0.060, wRref(F2) = 0.185, T = 298 K.
Crystal structure of 3,5-dinitro-2-pyridone, C5H3NO(NO2)2
Authors: Zhang G.-F. , She J.-B. , Dou Y.-L. , Fan R. 
Published: September 2014

Abstract C5H3N3O5, orthorhombic, Pna21 (no. 33), a = 12.335(4) Å, b = 9.636(3) Å, c = 5.738(2) Å, V = 682.0 Å3, Z = 4, Rgt(F) = 0.031, wRref(F2) = 0.085, T = 298 K.
Crystal structure of catena-aquatris(1H-imidazole-N)(μ-sulfato)copper(II), Cu(H2O)(C3H4N2)3(SO4)
Authors: Fu F. , Guo J.-X. , Li D.-S. , Tang L. , Zhang M.-L. , Wang J.-W. 
Published: September 2014

AbstractC9H14CuN6O5S, monoclinic, P121/n1 (no. 14), a = 11.723(2) Å, b = 8.651(2) Å, c = 13.839(3) Å, β = 91.703(4)°, V = 1402.8 Å3, Z = 4, Rgt(F) = 0.046, wRref(F2) = 0.133, T = 296 K.
Crystal structure of (3R,6S,4'S)-2-benzyl-3-(2',2'-dimethyl[1',3']dioxolan- 4'-yl)-4-methoxy-6-phenyl-3,6-dihydro-2H-1,2-oxazine, C23H27NO4
Authors: Chowdhury M. A. , Brüdgam I. , Hartl H. , Reißig H.-U. 
Published: September 2014

AbstractC23H27NO4, monoclinic, P1211 (no. 4), a = 10.053(3) Å, b = 9.859(3) Å, c = 10.202(3) Å, β = 96.087(6)°, V = 1005.4Å3, Z = 2, Rgt(F) = 0.054, wRref(F2) = 0.138, T = 173 K.
Crystal structure of 1,2,5-trimethyl-1,2,3,4-tetrahydropyrido[ 4,3-b]carbazole (guatambuine), C18H20N2, from Aspidosperma subincanum Mart.
Authors: De Simone C. A. , Malta V. R. S. , Lamenha G. S. , Humberto M. M. S. , Porto K. R. A. , Sant' Ana A. E. G 
Published: September 2014

Abstract C18H20N2, orthorhombic, P212121 (no. 19), a = 11.587(5) Å, b = 8.130(5) Å, c = 15.239(5) Å, V = 1435.5 Å3, Z = 4, Rgt(F) = 0.055, wRref(F2) = 0.137, T = 293 K.
Crystal structure of bismuth triiodate dihydrate, Bi[IO3]3 · 2H2O
Authors: Phanon D. , Gautier-Luneau I. 
Published: September 2014

Abstract BiH4I3O11, triclinic, P1̅ (no. 2), a = 7.056(2) Å, b = 7.337(1) Å, c = 10.740(1) Å, α = 95.06(1)°, β = 106.16(1)°, γ = 109.56(1)°, V = 493.0 Å3, Z = 2, Rgt(F) = 0.035, wRref(F2) = 0.090, T = 293 K.
Crystal structure of indium triiodate trihydrate, In[IO3]3 · 3H2O
Authors: Phanon D. , Gautier-Luneau I. 
Published: September 2014

Abstract H6I3InO12, triclinic, P1̅ (no. 2), a = 6.862(1) Å, b = 7.282(2) Å, c = 11.137(3) Å, α = 94.01(2)°, β = 107.75(1)°, γ = 93.59(1)°, V = 526.7 Å3, Z = 2, Rgt(F) = 0.034, wRref(F2) = 0.089, T = 293 K.
Crystal structure of potassium scandium (monophosphate-hydrogenmonoborate- monophosphate), KSc[BP2O8(OH)]
Authors: Menezes P. W. , Hoffmann S. , Prots Yu. , Kniep R. 
Published: September 2014

Abstract BHKO9P2Sc, triclinic, P1̅ (no. 2), a = 5.2696(2) Å, b = 8.2739(8) Å, c = 8.3890(5) Å, α = 88.22(1)°, β = 79.701(6)°, γ = 86.67(1)°, V = 359.2 Å3, Z = 2, Rgt(F) = 0.032, wRref(F2) = 0.075, T = 295 K.
Crystal structure of praseodymium dimolybdenum disilicide carbide, PrMo2Si2C
Authors: Dashjav E. , Schnelle W. , Wagner F. R. , Kreiner G. , Kniep R. 
Published: September 2014

Abstract CMo2PrSi2, tetragonal, P4/mmm (no. 123), a = 4.2139(3) Å, c = 5.4093(4) Å, V = 96.1 Å3, Z = 1, Rgt(F) = 0.020, wRref(F2) = 0.042, T = 295 K.
Crystal structure of carbohydrazidium(1+) p-toluenesulfonate, (NH2NHCONHNH3)[CH3C6H4SO3]
Authors: Yang L. , Yu W. , Wu T. , Zhang T.-L. , Zhang J.-G. , Guo J.-Y. , Wu R.-F. , Ren F.-J. 
Published: September 2014

Abstract C16H28N8O8S2, orthorhombic, Pbca (no. 61), a = 10.646(1) Å, b = 8.185(1) Å, c = 26.402(4) Å, V = 2300.6 Å3, Z = 4, Rgt(F) = 0.038, wRref(F2) = 0.093, T = 293 K.
Refinement of the crystal structure of (E)-1,3-diphenyl-2-propen-1-one, C15H12O
Authors: Wu M.-H. , Yang X.-H. , Zou W.-D. , Liu W.-J. , Li C. 
Published: September 2014

Abstract C15H12O, orthorhombic, Pbcn (no. 60), a = 10.932(1) Å, b = 11.860(1) Å, c = 17.996(2) Å, V = 2333.3 Å3, Z = 8, Rgt(F) = 0.060, wRref(F2) = 0.173, T = 292 K.
Crystal structure of 2′-hydroxyacetophenone nicotinoylhydrazone monohydrate, C14H15N3O3 · H2O
Authors: Tai X.-S. , Kong F.-Y. 
Published: September 2014

Abstract C14H15N3O3, triclinic, P1̅ (no. 2), a = 8.680(2) Å, b = 8.877(2) Å, c = 9.273(2) Å, α = 81.28(3)°, β = 86.26(3)°, γ = 70.48(3)°, V = 665.5 Å3, Z = 2, Rgt(F) = 0.064, wRref(F2) = 0.177, T = 291 K.
Crystal structure of bis(1,10-phenanthroline-N,N′)bis(2-chlorobenzoato)- lead(II) hydrate (1:2.5), [Pb(C7H4O2Cl)2(C12H8N2)2] · 2.5H2O
Authors: Guo H.-M. , Zhang B.-S. , Wang Y.-H. 
Published: September 2014

Abstract C38H29Cl2N4O6.5Pb, triclinic, P1̅ (no. 2), a = 11.548(2) Å, b = 12.532(3) Å, c = 13.661(3) Å, α = 95.34(3)°, β = 112.60(3)°, γ = 103.23(3)°, V = 1740.4 Å3, Z = 2, Rgt(F) = 0.037, wRref(F2) = 0.082, T = 293 K.
Crystal structure of bis[(1,3-bis(4-pyridinium)propane)]- [β-hexacosaoxooctamolybdate(VI)], (C13H16N2)2[Mo8O26]
Authors: Wang C.-C. 
Published: September 2014

Abstract C26H32Mo8N4O26, monoclinic, P121/c1 (no. 14), a = 10.589(2) Å, b = 10.007(2) Å, c = 19.662(4) Å, β = 100.85(3)°, V = 2046.2 Å3, Z = 2, Rgt(F) = 0.023, wRref(F2) = 0.056, T = 293 K.
Crystal structure of acetato-μ-N,N′-bis(salicylidene)-3-methyl- 3-aza-1,5-pentanediaminocobalt(III), Co(C2H3O2)(C21H25N3O2)
Authors: Xu S.-P. , Liu C.-H. , Wang S.-F. 
Published: September 2014

Abstract C23H28CoN3O4, monoclinic, P121/n1 (no. 14), a = 9.400(4) Å, b = 19.203(5) Å, c = 12.112(5) Å, β = 92.33°, V = 2184.5 Å3, Z = 4, Rgt(F) = 0.066, wRref(F2) = 0.202, T = 293 K.
Crystal structure of tetrakis[(4-methyl-pyridin-2-yl)-trimethylsilanylamido] zirconium(IV), Zr(C9H15N2Si)4
Authors: Noor A. , Irrgang T. , Kempe R. 
Published: September 2014

Abstract C36H60N8Si4Zr, triclinic, P1̅ (no. 2), a = 12.0360(6) Å, b = 18.8040(9) Å, c = 21.581(1) Å, α = 69.448(4)°, β = 75.278(4)°, γ = 88.159(4)°, V = 4414.5 Å3, Z = 4, Rgt(F) = 0.035, wRref(F2) = 0.101, T = 191 K.
Crystal structures of the methylene chloride disolvates of tetrakis(3,5- dimethoxyphenyl)porphyrin and its isotypic copper(II) and nickel(II) complexes, C52H46N4O8 · 2CH2Cl2, Cu(C52H44N4O8) · 2CH2Cl2, Ni(C52H44N4O8) · 2CH2Cl2
Authors: Zeller M. , DiMuzio S. J. , Bee K. , Clemente J. , Frederick J. , Fucci A. , Gordon L. , Harper A. , Kasmar A. , Kasmar C. , Polomsky S. , Simmons A. , Smallsreed D. , Underwood T. , Hunter A. D. 
Published: September 2014

Abstract C54H50Cl4N4O8, triclinic, P1̅ (no. 2), a = 11.295(1) Å, b = 11.255(1) Å, c = 11.797(1) Å, α = 108.904(2)°, β = 101.091(2)°, γ = 110.992(2)°, V = 1241.4 Å3, Z = 1, Rgt(F) = 0.056, wRref(F2) = 0.135, T = 100 K.C54H48Cl4CuN4O8, triclinic, P1̅ (no. 2), a = 11.2204(5) Å, b = 11.3499(6) Å, c = 11.7610(6) Å, α = 109.187(1)°, β = 100.830(1)°, γ = 110.681(1)°, V = 1242.7 Å3, Z = 1, Rgt(F) = 0.033, wRref(F2) = 0.092, T = 100 K.C54H48Cl4N4NiO8, triclinic, P1̅ (no. 2), a = 11.196(1) Å, b = 11.329(1) Å, c = 11.785(1) Å, α = 109.486(2)°, β = 101.230(2)°, γ = 110.607(2)°, V = 1233.8 Å3, Z = 1, Rgt(F) = 0.040, wRref(F2) = 0.110, T = 100 K.
Crystal structure of bis(2,2′-biimidazol-1-ium) tetrachloroferrate(III) chloride, (C6H7N4)2[FeCl4]Cl
Authors: Hu M.-L. , Chen F. 
Published: September 2014

Abstract C12H14Cl5FeN8, monoclinic, P121/c1 (no. 14), a = 7.1902(5) Å, b = 12.7155(9) Å, c = 21.753(2) Å, β = 96.405(1)°, V = 1976.4 Å3, Z = 4, Rgt(F) = 0.085, wRref(F2) = 0.166, T = 298 K.
Crystal structure of theophylline-7-acetic acid, C9H10N4O4
Authors: Zhang L.-J. , Liu M.-C. , Ding J.-C. , Wu H.-Y. 
Published: September 2014

Abstract C9H10N4O4, monoclinic, P121/n1 (no. 14), a = 9.542(1) Å, b = 7.2415(9) Å, c = 14.446(2) Å, β = 98.657(2)°, V = 986.8 Å3, Z = 4, Rgt(F) = 0.053, wRref(F2) = 0.138, T = 298 K.
Crystal structure of N, N′-bis(salicylidene)-1,10-decanediamine, C10H20(NCHC6H4OH)2
Authors: Yu Y.-Y. 
Published: September 2014

Abstract C24H32N2O2, monoclinic, C12/c1 (no. 15), a = 46.409(9) Å, b = 4.800(1) Å, c = 9.987(2) Å, β = 98.10(3)°, V = 2202.4 Å3, Z = 4, Rgt(F) = 0.047, wRref(F2) = 0.142, T = 296 K.
Crystal structure of N-(diphenyl)methyl-N-(3′,3′-dimethyl-2′-oxo)butyl- 2(R),3(R)-epoxybutyramide, C23H27NO3
Authors: Tinant B. , Laurent M. , Marchand-Brynaert J. 
Published: September 2014

Abstract C23H27NO3, monoclinic, P1211 (no. 4), a = 8.669(3) Å, b = 22.880(5)Å, c = 10.220(3)Å, β = 96.04(2)°, V = 2015.9Å3, Z = 4, Rgt(F) = 0.039, wRref(F2) = 0.106, T = 125 K.
Crystal structures of catena-(tris(μ-betaine-O,O′)manganese(II)) tetrachlorozincate and catena-(tris(μ-betaine-O,O′)manganese(II)) tetrachlorocobaltate, [{(CH3)3NCH2COO}3Mn][MCl4] (M= Zn, Co)
Authors: Wiehl L. , Schreuer J. , Haussühl E. 
Published: September 2014

Abstract C15H33Cl4MnN3O6Zn, trigonal, P3̅ (no. 147), a = 12.7751(5) Å, c = 9.0835(2) Å, V = 1283.9 Å3, Z = 2, Rgt(F) = 0.032, wRref(F2) = 0.083, T = 293 K.C15H33Cl4CoMnN3O6, trigonal, P3̅ (no. 147), a = 12.7832(7) Å, c = 9.0769(4) Å, V = 1284.6 Å3, Z = 2, Rgt(F) = 0.028, wRref(F2) = 0.076, T = 293 K.
Crystal structure of dimethyl (2S,3R,3aS,4S,5R,6R)-6-iodomethyl-4,5- isopropylidenedioxy-hexahydropyrrolo[1,2-b]pyrazole-2,3-dicarboxylate, C14H21IN2O6
Authors: Frey W. , Shaw D. , Jégou A. , Jäger V. 
Published: September 2014

Abstract C14H21IN2O6, orthorhombic, P212121 (no. 19), a = 9.748(1) Å, b = 11.701(2) Å, c = 15.552(2) Å, V = 1773.9 Å3, Z = 4, Rgt(F) = 0.050, wRref(F2) = 0.120, T = 293 K.
Crystal structure of bis(1,10-phenanthroline-N,N′)bis(2,4-dimethylbenzoato- O,O′)tetrakis(μ-2,4-dimethylbenzoato-O,O′)disamarium(III), Sm2(C9H9O2)6(C12H8N2)2
Authors: Zhang T.-T. , Li X. , Ju Y.-L. 
Published: September 2014

Abstract C78H70N4O12Sm2, monoclinic, C12/c1 (no. 15), a = 27.523(3) Å, b = 15.699(2) Å, c = 16.048(2) Å, β = 101.123(2)°, V = 6803.7 Å3, Z = 4, Rgt(F) = 0.026, wRref(F2) = 0.063, T = 294 K.
Painful fat necrosis resulting from insulin injections
Authors: Hanson P , Pandit M , Menon V , Roberts S , Barber T M 
Published: September 2014

SummaryThe case is a 34-year-old woman with long-standing type 1 diabetes mellitus with existing follow-up in the outpatient clinic at the Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, UHCW. She had maintained good glycaemic control and glycaemic stability with basal bolus regimen for many years. She had not developed any diabetes-related complications and had no other co-morbidities. Six months ago, she presented to A&E with sudden-onset, well-localised and severe pain in the right iliac fossa, just lateral to the para-umbilical area. Her biochemistry was normal. Ultrasound scan, however, revealed a right-sided ovarian cyst, which was thought to have caused pain to her. She was discharged from A&E with simple analgesia. On subsequent gynaecological follow-up 4 weeks later, her pain remained severe and examination revealed an exquisitely tender subcutaneous nodule at the same location measuring 2 cm in diameter. Magnetic resonance imaging (MRI) scan at the time revealed a 1 cm mass in the subcutaneous adipose tissue, which co-localised to her pain. The mass demonstrated a central fat signal surrounded by a peripheral ring: observations consistent with fat necrosis. There were other smaller subcutaneous nodules also observed in the left para-umbilical area. Subsequent surgical resection of the main area of fat necrosis was performed. The patient made an excellent recovery and her pain resolved post-operatively. Histology confirmed the presence of fat necrosis. Fat necrosis is a rare complication of s.c. insulin injection. This case illustrates the importance of considering this diagnosis in patients who inject insulin and develop localised injection-site pain.Learning pointsFat necrosis is a rare complication of insulin injections that can manifest with severe, persistent and well-localised pain.Fat necrosis can masquerade as other pathologies causing diagnostic confusion.The imaging modality of choice for accurate diagnosis of fat necrosis is MRI.Histological confirmation of fat necrosis is important.Appropriate management of localised fat necrosis is surgical excision, with avoidance of further insulin injections into the affected area.
Spectrum Migration Approach Based on Pre-decision Aid and Interval Mamdani Fuzzy Inference in Cognitive Radio Networks
Authors: Wang Zhendong , Wang Huiqiang , Lv Hongwu , Feng Guangsheng 
Published: September 2014

This study intends to improve the QoS of SUs and CRNs performance. A novel spectrum migration approach based on pre-decision aid and interval Mamdani fuzzy inference is presented. we first define spectrum migration factors as spectrum characteristic metrics for spectrum migration decision. In addition, we use predecision aid to reduce system complexity and improve spectrum migration efficiency. To shorten spectrum migration decision time and seek the optimal spectrum holes, interval Mamdani fuzzy inference is put forward. Finally, simulation results show the proposed approach can inhibit the upward trend of service retransmission probability and average migration times effectively, and improve the effective utilization of CRNs spectrum resource significantly.